Insmed Inc (INSM.OQ)
9.72USD
1 Jul 2013
$-2.24 (-18.73%)
$11.96
$9.23
$10.62
$9.01
757,342
114,390
$14.30
$2.86
INSM.OQ
About
Overall
| Beta: | -0.17 |
| Market Cap (Mil.): | $380.27 |
| Shares Outstanding (Mil.): | 31.80 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| INSM.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 34.05 | 33.02 |
| EPS (TTM): | -1.69 | -- | -- |
| ROI: | -38.28 | -2.50 | 19.07 |
| ROE: | -40.90 | -3.10 | 20.00 |
UPDATE 2-Insmed's lung infection drug fares no better than rival, shares fall
* Drug shows smaller improvement in lung capacity vs rival
Insmed's lung infection drug succeeds in late-stage trial
July 1 - Insmed Inc said a late-stage trial of its experimental lung infection drug showed the therapy was as effective as another approved treatment.
Competitors
| Price | Change | |
|---|---|---|
| Novartis AG (NOVN.VX) | CHF67.30 | +0.20 |
| Bayer AG (BAYGn.DE) | €82.37 | +0.44 |
| Bayer AG (BAYE.F) | -- | -- |
| Gilead Sciences, Inc. (GILD.OQ) | $51.65 | +0.44 |
| Forest Laboratories, Inc. (FRX.N) | $41.72 | +0.72 |
| Vertex Pharmaceuticals Incorporated (VRTX.OQ) | $80.43 | +0.56 |
| Aradigm Corporation (ARDM.OB) | $0.15 | -0.01 |
Earnings vs. 
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: ValuEngine, Inc.
|
$127.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
